top of page
  • Writer's pictureOutbound Pharma

Outbound Pharma Appoints Aljosa Zavisic, Ph.D. as Senior Consultant, EU markets

Dec 21st, 2023


OUTBOUND PHARMA announces that Dr. Aljosa Zavisic has been appointed as the new Senior Consultant, European markets. An experienced business development professional, Dr. Zavisic will assume client responsibilities effective immediately.


The move marks an inflection point in OUTBOUND PHARMA’s growth as the company aggressively expands its appointment setting services on a more global scale, seeking to bring in the best business development and lead generation professionals in the life science industry.


Aljosa Zavisic ,Senior Consultant for EU markets

"Aljosa has an outstanding curriculum in biotechnology and genomics complemented by a strong business development background and excellent customer oriented mindset” - Claudio Rota, Managing Director at OUTBOUND PHARMA.


Dr. Zavisic's impressive background includes sales and business development management roles at leading companies like Oxford Gene Technology (OGT), Illumina and Ardigen. He has a Ph.D. in Plant Physiology from the University of Göttingen. Because of his international background, he is fluent in three languages: English, German and Serbo-Croatian. We look forward to welcoming Dr. Zavisic to OUTBOUND PHARMA.


Outbound Pharma is a specialized lead generation and business development consultancy that empowers B2B life science businesses to achieve growth. Our core expertise lies in account-based sales and business development, all of which play pivotal roles in our effective lead generation campaigns. With a rich experience spanning over 7 years, we have consistently served as a reliable partner for B2B life science companies in their pursuit of generating leads. Our unwavering focus revolves around assisting sales and marketing teams in creating a steady stream of qualified leads. We are dedicated to continuously exploring innovative approaches to enhance lead generation for professionals in the industry.






Komentáře


bottom of page